Email This Article
Headlines & Perspectives
How Encysive Botched the FDA Game
By
Melissa Davis
06/30/07 - 11:56 AM EDT
It cries foul when its key drug fails to get approved, but its own missteps led to setbacks.
TheStreet Premium Services For Personal Service: 877-471-2967
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
ETF Profits:
Get money-making ideas from the hottest investment vehicle on the planet. Our experts show you how to play various ETF sectors to help pump-up your portfolio. Learn More
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 12,778.75 | 1,341.57 | 2,909.88 | 19.65 |
Oil *
117.32
|
|
DOWN
111.71 |
DOWN
10.38 |
DOWN
17.35 |
DOWN
0.82 |
10 Yr
1.96%
SPDR Gold
167.16
|
|
-0.87%
|
-0.77%
|
-0.59%
|
-4.01%
|
Data delayed 20 minutes |
Connect with TheStreet